Testing effectiveness (Phase 2)Study completedNCT00055471
What this trial is testing
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Who this might be right for
Prostatic NeoplasmsMetastases, Neoplasm
AstraZeneca 22